The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial

NCT02885545 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Failure to recruit any participants in more than one year of recruiting.

Conditions

Chronic Kidney Disease
Acute Bleeding
Cerebrovascular Stroke

Interventions

DEVICE: Watchman
DRUG: Continued therapy with the prescribed oral anticoagulant

Sponsor

Population Health Research Institute